Merck KGaA (FRA:MRK) has been given a €103.00 ($110.75) price objective by research analysts at Morgan Stanley in a report released on Thursday. The brokerage currently has a a “neutral” rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Citigroup Inc. reiterated a “buy” rating on shares of Merck KGaA in a research note on Wednesday. Societe Generale set a €97.00 ($104.30) target price on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Wednesday. DZ Bank AG restated a “buy” rating on shares of Merck KGaA in a research note on Wednesday. Berenberg Bank set a €101.00 ($108.60) target price on shares of Merck KGaA and gave the company a “buy” rating in a research note on Friday, July 22nd. Finally, equinet AG set a €91.00 ($97.85) target price on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Tuesday. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating and ten have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of €101.60 ($109.24).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) opened at 94.31 on Thursday. The company’s 50 day moving average is €95.61 and its 200 day moving average is €92.97. The stock has a market cap of €41.00 billion and a P/E ratio of 29.51. Merck KGaA has a 52 week low of €70.87 and a 52 week high of €100.00.

Merck KGaA Company Profile

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.